TY  - CHAP
M1  - Book, Section
TI  - Chapter 56. Mammographic and Intraoperative Ultrasound Guidance
A1  - Fine, Richard E.
A2  - Kuerer, Henry M.
PY  - 2010
T2  - Kuerer's Breast Surgical Oncology
AB  - An  increasing  number  of  nonpalpable  breast  lesions  are  identified  due  to  screening  mammography  and  breast  magnetic  resonance  imaging  (MRI).  After  appropriate  diagnostic  imaging  workup,  many  of  these  image-detected  abnormalities  require  a  biopsy  for  pathologic  confirmation.  The  positive  predictive  value  of  mammography  (the  number  of  cancers  diagnosed  per  number  of  biopsies  recommended)  historically  has  ranged  from  15%  to  35%.1  Fortunately,  a  substantial  number  of  these  lesions  are  initially  evaluated  with  percutaneous  image-guided  breast  biopsy,  providing  a  less  costly,  less  invasive  method  to  obtain  an  accurate  diagnosis  without  sacrificing  accuracy.  After  a  benign  diagnosis  is  obtained  with  a  minimally  invasive  image-guided  biopsy,  no  further  workup  is  recommended,  and  the  patient  is  placed  in  an  established  follow-up  protocol.  The  goal  of  reserving  open  surgical  biopsy  for  definitive  clinical  management  and  eliminating  it  for  the  sole  purpose  of  diagnosis  is  increasingly  being  accomplished.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesssurgery.mhmedical.com/content.aspx?aid=6413937
ER  -